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Abstract	  The	  spinal	  cord	  innervates	  all	  peripheral	  organs	  and,	  accordingly,	  spinal	  cord	  injury	  (SCI)	   has	   a	   chronic	   negative	   effect	   on	   peripheral	   organ	   function.	   As	   such,	   SCI	  patients	   have	  many	   chronic	  medical	   conditions	   that	   reduce	   health,	   life	   span,	   and	  quality	  of	  life.	  Metabolic	  syndrome	  is	  one	  such	  condition	  with	  high	  prevalence	  in	  the	  SCI	  population.	  The	  liver	  is	  essential	  for	  regulation	  of	  metabolism,	  and	  pathological	  changes	   in	   the	   liver	   contribute	   directly	   to	   developing	   metabolic	   syndrome.	  Surprisingly,	  the	  potential	  for	  SCI	  to	  disrupt	  liver	  functions	  has	  not	  been	  thoroughly	  examined.	   Therefore,	   we	   tested	   the	   hypothesis	   that	   SCI	   causes	   chronic	   liver	  pathology	   and	   dysfunction.	   Adult	   female	   rats	  were	   used	   as	   a	  model	   organism	   for	  spinal	  cord	  injury.	  Animals	  were	  perfused	  at	  different	  time	  points	  following	  SCI	  and	  tissue	   samples	   were	   collected	   for	   histological	   and	   molecular	   analyses.	   Adipose	  tissue	   showed	  changed	  expression	  of	   the	  adipokines	   resistin	  and	  adiponectin	   that	  modify	   inflammatory	   and	   metabolic	   function	   after	   injury.	   Significant	   lipid	  accumulation	  in	  the	  liver	  occurred	  by	  1	  day	  post	  injury	  (dpi)	  and	  remained	  elevated	  for	   at	   least	   21	   dpi	   compared	   to	   non-­‐injured	   control	   animals.	   Detailed	   lipidomic	  analysis	   revealed	   that	   the	   increased	   lipid	   content	   is	   coupled	   with	   changes	   in	   the	  proportions	  of	  specific	  cytotoxic	  ceramide	  species.	  Coincident	  with	  the	  alterations	  in	  lipid	   content,	   inflammation	   increased	   acutely	   in	   the	   liver	   and	   remained	   elevated	  through	  21	  dpi.	  Inflammatory	  changes	  included	  hepatic	  macrophage	  activation	  from	  increased	   expression	   of	   interleukin	   inflammatory	   factors	   and	   TNF-­‐α.	   Liver	  dysfunction	  is	  similar	  in	  rats	  receiving	  cervical	  or	  mid-­‐thoracic	  SCI,	  suggesting	  these	  same	  effects	  likely	  occur	  in	  a	  large	  percentage	  of	  the	  SCI	  population.	  Given	  the	  liver’s	  essential	   role	   in	  metabolic	   function	   and	   the	   known	  metabolic	   problems	   after	   SCI,	  understanding	  the	  extent	  and	  cause	  of	  liver	  dysfunction	  following	  SCI	  may	  identify	  novel	  therapeutic	  targets	  for	  improving	  health,	  longevity,	  and	  quality	  of	  life	  for	  SCI	  patients.	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Introduction	  
	   Affecting	   over	   270,000	   people	   with	   12,000	   new	   cases	   every	   year31,	   spinal	  cord	   injury	   (SCI)	   is	   a	   chronic	   condition	   affecting	   the	   lives	   of	  many	   Americans.	   As	  survival	  rates	  improve	  from	  the	  initial	  spinal	  cord	  trauma,	  the	  deleterious	  effects	  of	  various	   secondary	   pathologies	   are	   becoming	   better	   known1.	   The	   spinal	   cord	  innervates	   all	   peripheral	   organs	   and,	   accordingly,	   SCI	   has	   been	   shown	   to	   have	   a	  chronic	   negative	   effect	   on	   peripheral	   organ	   function.	   As	   such,	   SCI	   patients	   have	  many	  chronic	  medical	  conditions	  that	  reduce	  health,	   life	  span,	  and	  quality	  of	   life31.	  Metabolic	   syndrome	   is	   one	   such	   condition	   with	   high	   prevalence	   in	   the	   SCI	  population4.	   The	   liver	   is	   essential	   for	   regulation	   of	   metabolism,	   and	   pathological	  changes	  in	  the	  liver	  contribute	  directly	  to	  developing	  metabolic	  syndrome,	  which	  is	  associated	  with	  cardiovascular	  impairment,	  peripheral	  inflammation,	  and	  increased	  risk	  of	  death9.	  While	  some	  studies	  have	  aimed	  to	  elucidate	  the	  changes	  in	  the	  liver	  following	  SCI,	   the	  role	  of	  spinal	  cord	   injury	   level	  on	  degree	  of	  dysfunction	  has	  not	  been	  examined.	  The	  present	  study	  seeks	  to	  determine	  the	  cause	  and	  extent	  of	  liver	  dysfunction	   following	  spinal	  cord	   injury	  at	  different	   levels	  of	   trauma,	  as	  well	  as	   to	  further	  characterize	  the	  array	  of	  metabolic	  and	  inflammatory	  changes	  after	  injury.	  Adipose	   tissue	   has	   been	   indicted	   in	   both	   metabolic	   and	   inflammatory	  changes.	  Adipocytes	  were	  once	  considered	  storage	  vessels	  for	  lipids,	  but	  have	  now	  been	   recognized	   for	   their	   important	   endocrine	   functionality15,22.	   Adipose	   tissue	   is	  capable	   of	   regulating	   both	  metabolic	   and	   inflammatory	   changes.	   Because	   of	   these	  roles,	   adipose	   tissue	   is	   considered	   to	   be	   the	   most	   prominent	   factor	   in	   systemic	  inflammation22,32.	   In	   cases	  of	  obesity	  and	  high	  percentage	  body	   fat,	   adipose	   tissue	  can	   become	   dysfunctional	   and	   release	   excessive	   signaling	   factors	   that	   lead	   to	  inflammation	  and	  insulin	  resistance.	  Endocrine	  proteins	  released	  by	  adipocytes	  are	  referred	   to	   as	   adipokines,	   the	   most	   prominent	   being	   resistin,	   leptin,	   and	  adiponectin.	  Resistin	  and	  leptin	  are	  pro-­‐inflammatory	  adipokines	  usually	  present	  in	  lower	  concentrations	  in	  the	  serum.	  Leptin	  is	  highly	  involved	  in	  metabolic	  function,	  specifically	   in	  monitoring	   satiety	   and	   hunger.	   Resistin	   is	   involved	   in	   regulation	   of	  metabolism	   through	   modifying	   blood	   glucose	   concentration,	   and	   also	   acts	   in	   an	  inflammatory	  manner	  itself	  and	  by	  increasing	  expression	  of	  other	  pro-­‐inflammatory	  cytokines.	  Adiponectin	  acts	   to	  counteract	  many	  of	   the	  effects	  produced	  by	  resistin	  and	  leptin.	  It	  has	  been	  shown	  to	  counteract	  the	  symptoms	  of	  metabolic	  dysfunction	  and	   reduce	   systemic	   inflammation.	   The	   described	   functions	   of	   adipose	   tissue	   and	  adipokines	   indicate	   change	   to	   their	   expression	   after	   spinal	   cord	   injury	   could	   be	  involved	  in	  metabolic	  dysfunction.	  	  Adipose	   tissue	   is	   certainly	  a	  key	  player	   in	  metabolic	   function,	  but	   the	  most	  important	  metabolic	  organ	  of	  the	  body	  must	  play	  a	  role	  in	  any	  dysfunction	  as	  well.	  Liver	   dysfunction	   can	   lead	   to	   an	   array	   of	   physiological	   changes	   that	   can	   be	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   The	  initial	  mechanical	  trauma	  from	  SCI	  is	  devastating	  to	  proper	  somatic	  and	  autonomic	  function	  of	  the	  nervous	  system.	  The	  damage	  severs	  connections	  between	  the	  central	  nervous	  system	  and	  its	  peripheral	  targets,	  and	  causes	  neuron	  death	  and	  decay.	  This	  dysfunction	  is	  only	  compounded	  when	  secondary	  effects	  disrupt	  the	  healing	  process.	  Neuroglia	  and	  immune	  cells	  respond	  to	  the	  sudden	  change	  by	  forming	  a	  barrier	  around	  the	  injury	  epicenter	  known	  as	  the	  glial	  scar44.	  While	  the	  glial	  scar	  formation	  is	  part	  of	  the	  body’s	  innate	  response	  to	  allow	  for	  proper	  healing,	  the	  scar	  formation	  is	  more	  detrimental	  than	  beneficial	  in	  spinal	  cord	  injury.	  The	  glial	  and	  immune	  cells	  that	  form	  the	  scar	  prevent	  axonal	  regrowth	  through	  the	  injury	  site.	  The	  inhibition	  of	  axonal	  regrowth	  combined	  with	  neuron	  death	  and	  decay	  from	  the	  initial	  trauma	  causes	  physiological	  functions	  that	  are	  regulated	  by	  the	  now	  damaged	  nervous	  system	  to	  run	  independently.	  Maintenance	  of	  homeostasis	  may	  persist	  without	  autonomic	  control	  from	  the	  nervous	  system,	  but	  any	  imbalance	  could	  be	  enough	  to	  shift	  the	  equilibrium	  of	  a	  system	  to	  dysfunction.	  This	  dysfunction	  can	  be	  the	  result	  of	  the	  many	  physiological	  imbalances	  created	  after	  spinal	  cord	  injury	  for	  the	  connections	  of	  the	  immune	  system,	  adipose	  tissue,	  and	  the	  liver18.	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   The	  liver	  is	  the	  main	  metabolic	  organ	  of	  the	  body	  with	  autonomic	  innervation	  that	  mostly	  originates	  from	  thoracic	  vertebra	  7	  cord	  level	  (T7)	  to	  T1243.	  The	  liver	  is	  subject	  to	  CNS	  control	  through	  direct	  sympathetic	  connections	  from	  the	  spinal	  cord	  as	  well	  as	  descending	  parasympathetic	  pathways.	  The	  autonomic	  control	  of	  liver	  activity	  can	  be	  adversely	  affected	  by	  damage	  to	  any	  neurons	  involved	  in	  the	  pathway	  by	  spinal	  cord	  injury.	  This	  damage	  can	  be	  further	  compounded	  by	  dysfunction	  in	  other	  systems	  that	  act	  in	  the	  liver,	  such	  as	  the	  immune	  system.	  Spinal	  cord	  injury	  has	  previously	  been	  shown	  to	  release	  leukocytes	  and	  inflammatory	  cytokines	  into	  circulation	  within	  hours	  after	  the	  initial	  trauma8,24.	  As	  these	  cytokines	  and	  immune	  cells	  matriculate	  through	  the	  liver,	  dysfunction	  is	  exacerbated	  by	  increased	  inflammation.	  In	  addition	  to	  the	  changes	  occurring	  in	  the	  liver,	  fat	  cells	  housed	  in	  adipose	  tissue	  respond	  to	  the	  trauma	  as	  part	  of	  the	  acute	  phase	  of	  the	  innate	  response12,20.	  Fat	  cells	  mobilize	  free	  fatty	  acids	  (FFAs)	  by	  hydrolysis	  of	  stored	  triglycerides	  for	  delivery	  to	  the	  liver.	  All	  these	  changes	  happen	  within	  hours	  after	  the	  initial	  trauma.	  Under	  normal	  physiological	  circumstances,	  these	  changes	  result	  in	  preparation	  of	  the	  body	  for	  a	  reparative/protective	  response.	  However,	  with	  injury	  to	  the	  regulatory	  functions	  provided	  by	  the	  nervous	  system,	  damage	  can	  accrue	  and	  persist	  chronically.	  Normally,	  these	  FFAs	  are	  converted	  into	  glucose	  to	  power	  the	  physiological	  machinery	  needed	  to	  react	  to	  the	  
mechanical	  injury25.	  However,	  in	  the	  case	  of	  spinal	  cord	  injury,	  the	  excess	  of	  FFAs	  may	  be	  too	  great	  for	  complete	  conversion	  to	  glucose	  or	  export	  from	  the	  liver.	  As	  such,	  excess	  lipids	  accumulate	  in	  the	  liver	  as	  soon	  as	  1	  dpi	  as	  shown	  in	  Fig	  1.1.	  The	  lipid	  content	  and	  droplet	  size,	  both	  indicators	  of	  liver	  pathology,	  are	  increased	  after	  injury.	  This	  histology	  is	  consistent	  with	  NAFLD,	  and	  its	  rapid	  onset	  after	  SCI	  indicates	  the	  trauma	  and	  its	  after-­‐effects	  are	  sufficient	  to	  induce	  dysfunction.	  While	  
Figure	  1.1:	  Lipid	  accumulation	  in	  the	  liver	  is	  significant	  as	  soon	  as	  1	  dpi.	  The	  increase	  in	  lipids	  marked	  by	  Oil	  Red	  O	  staining	  in	  (A)	  mimics	  the	  pattern	  followed	  by	  inflammation	  where	  intermediate	  time	  points	  trend	  towards	  an	  increase	  but	  are	  not	  statistically	  significant	  in	  (B).	  The	  size	  of	  these	  lipid	  droplets	  changes	  also	  after	  injury	  as	  shown	  in	  (C).	  
	   8	  
only	  10-­‐25%	  of	  NAFLD	  cases	  progress	  to	  NASH6,23,	  enhanced	  liver	  inflammation	  is	  already	  present	  after	  SCI,	  indicating	  a	  more	  rapid	  progression	  to	  NASH-­‐like	  pathology.	  	   This	  chronic	  persistence	  of	  pathological	  changes	  to	  the	  liver	  can	  be	  observed	  as	  early	  as	  a	  few	  hours	  after	  injury.	  The	  inflammatory	  state	  of	  the	  liver	  changes	  rapidly	  after	  injury	  and	  stays	  elevated	  out	  to	  21	  dpi.	  The	  increased	  inflammation	  state	  from	  SCI	  leads	  to	  prolonged	  activation	  of	  Kupffer	  cells,	  macrophages	  localized	  to	  the	  liver,	  as	  evidenced	  by	  increased	  CD68-­‐positive	  staining	  within	  liver	  tissue	  as	  shown	  in	  Fig	  1.2	  (A)	  and	  (B)	  at	  21	  dpi.	  Changes	  to	  the	  expression	  profile	  of	  the	  CD68	  
gene	  occur	  in	  a	  more	  rapid	  time	  course.	  CD68	  expression	  levels	  are	  increased	  as	  soon	  as	  1	  dpi	  and	  stay	  elevated	  out	  to	  the	  chronic	  21	  dpi	  time	  point.	  The	  chronic	  liver	  inflammation	  observed	  is	  pathological	  in	  nature,	  and	  further	  confirms	  development	  of	  liver	  dysfunction	  following	  spinal	  cord	  injury.	  The	  steatosis	  of	  liver	  cells	  paired	  with	  the	  chronic	  inflammation	  is	  concerning	  because	  of	  the	  damage	  to	  hepatocytes	  and	  liver	  function.	  Both	  histological	  markers	  are	  present	  for	  NASH,	  and	  liver	  damage	  due	  to	  this	  pathophysiology	  has	  been	  confirmed	  by	  serum	  assays	  that	  assess	  liver	  function.	  	  The	  liver	  pathology	  is	  confirmed	  from	  increased	  serum	  levels	  of	  alanine-­‐transaminase	  (ALT),	  a	  clinical	  marker	  of	  liver	  pathology.	  ALT	  is	  produced	  in	  abundant	  levels	  within	  liver	  cells,	  and	  this	  enzyme	  leaks	  into	  the	  blood	  serum	  in	  cases	  of	  hepatocyte	  damage	  due	  to	  increased	  membrane	  permeability.	  As	  shown	  in	  Fig	  1.3,	  serum	  content	  of	  ALT	  is	  significantly	  increased	  at	  21	  dpi	  –	  the	  same	  point	  at	  which	  liver	  lipid	  accumulation	  and	  inflammation	  reaches	  significance.	  The	  increase	  
Fig	  1.2:	  The	  increased	  inflammatory	  state	  of	  the	  liver	  is	  evident	  in	  tissue	  staining	  and	  gene	  expression.	  CD68-­‐positive	  macrophages	  are	  stained	  black	  in	  liver	  tissue	  in	  (A)	  and	  quantified	  in	  (B).	  Gene	  expression	  of	  CD68	  is	  also	  increased	  as	  soon	  as	  1	  dpi	  and	  significantly	  elevated	  out	  to	  21	  dpi	  as	  evidenced	  by	  RT-­‐PCR	  data	  in	  (C).	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Spinal	  Cord	  Injury	  Methodology	  	  Spinal	  cord	  injury	  was	  performed	  using	  the	  Sprague-­‐Dawley	  rat	  as	  a	  clinically	  relevant	  model	  for	  SCI.	  All	  procedures	  performed	  on	  animals	  were	  approved	  for	  use	  
Figure	  1.3:	   Serum	  levels	  of	   alanine	   transaminase	   (ALT)	  are	   increased	  significantly	  at	  14	  and	  21	  dpi,	  further	  confirming	  the	  pathology	  associated	  with	  inflammation	  and	  lipid	  accumulation.	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by	  IACUC	  and	  conformed	  to	  all	  standards	  set	  forth	  by	  the	  NIH	  and	  The	  Ohio	  State	  University	  animal	  care	  guidelines.	  Rats	  (220-­‐280g;	  Harlan,	  Houston,	  TX)	  were	  anesthetized	  by	  an	  intraperitoneal	  injection	  of	  a	  solution	  of	  ketamine	  (80	  mg/kg)	  and	  xylazine	  (10	  mg/kg).	  A	  dorsal	  laminectomy	  was	  performed	  at	  either	  the	  cervical-­‐vertebre	  level	  5	  (C5)	  or	  thoracic-­‐vertebre	  level	  8	  (T8).	  Rats	  were	  then	  injured	  by	  the	  Infinite	  Horizons	  device	  (Precision	  Systems	  and	  Instrumentation)	  to	  produce	  a	  spinal	  cord	  contusion	  injury	  with	  200	  kD	  of	  force.	  Animals	  were	  allowed	  to	  recover	  after	  closing	  the	  injury	  site	  and	  subcutaneous	  administration	  of	  5	  mL	  saline	  solution.	  	  
Gene	  Expression	  Analysis	  
	  Rats	  were	  sacrificed	  at	  variable	  times	  following	  injury	  (1-­‐28	  dpi)	  by	  intraperitoneal	  administration	  of	  a	  lethal	  dose	  of	  ketamine	  (120	  mg/kg)	  and	  xylazine	  (15	  mg/kg)	  and	  transcardially	  perfused	  with	  0.1M	  phosphate	  buffered	  saline	  (PBS).	  The	  liver,	  adipose	  tissue,	  and	  spinal	  cord	  were	  removed	  and	  immediately	  homogenized	  in	  Trizol	  (15596018,	  Life	  Technologies)	  for	  preservation	  of	  nucleic	  acids.	  Following	  thorough	  homogenization,	  samples	  were	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80	  °C	  until	  analysis.	  RNA	  was	  purified	  from	  samples	  by	  differential	  precipitation	  and	  centrifugation	  by	  standard	  chloroform/phenol	  protocol2.	  Purity	  was	  assessed	  by	  microdrop	  spectrophotometry	  before	  amplification.	  RNA	  was	  then	  synthesized	  into	  DNA	  using	  random	  primers	  and	  MMLV	  RNA-­‐dependent	  DNA-­‐polymerase	  enzyme	  to	  create	  cDNA.	  Quantitative	  Real-­‐Time	  Polymerase	  Chain	  Reaction	  (Applied	  Biosystems)	  was	  used	  to	  examine	  gene	  expression	  of	  the	  various	  genes	  described	  throughout	  the	  following	  section.	  Expression	  levels	  of	  each	  sample	  were	  normalized	  to	  18S	  gene	  expression	  and	  mRNA	  quantities	  calculated	  by	  the	  ΔΔCT	  methods36.	  	  
Tissue	  Removal	  and	  Preparation	  
	  Animals	  were	  sacrificed	  at	  the	  appropriate	  time	  post	  injury	  as	  described	  above.	  After	  the	  tissue	  was	  cleared	  of	  blood	  using	  0.1M	  PBS,	  animals	  were	  perfused	  with	  400	  mL	  of	  4%	  paraformaldehyde	  (PFA).	  The	  cross-­‐linking	  polymerization	  reaction	  of	  the	  PFA	  fixed	  the	  tissue	  in	  place	  to	  stabilize	  the	  tissue	  for	  analysis.	  Livers	  were	  removed	  and	  post-­‐fixed	  in	  4%	  PFA	  for	  2	  hours	  and	  then	  transferred	  to	  0.1M	  phosphate	  buffer	  (PB)	  overnight.	  The	  next	  day,	  livers	  were	  removed	  from	  PB	  and	  placed	  in	  30%	  sucrose	  solution	  for	  3	  days.	  The	  livers	  were	  then	  frozen	  on	  dry	  ice	  and	  blocked	  in	  optimal	  cutting	  temperature	  solution	  (OCT)	  to	  be	  cut	  into	  10	  μm	  slices	  in	  a	  cryostat	  and	  mounted	  on	  slides	  (Superfrost	  Plus	  Slides,	  Fisher	  Scientific).	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The	  tissue	  was	  cut	  in	  OCT	  at	  -­‐20	  °C	  and	  slides	  were	  stored	  at	  the	  same	  temperature	  until	  immunohistochemistry	  (IHC)	  analysis.	  	  
Histological	  Analysis	  of	  Liver	  Tissue	  	  IHC	  was	  performed	  to	  analyze	  macrophage	  inflammation	  in	  liver	  tissue.	  CD68	  antibody	  (Serotec,	  MCA341R,	  1:2,000)	  was	  used	  to	  visualize	  hepatic	  macrophages.	  Oil	  Red	  O	  staining	  was	  used	  for	  analysis	  of	  liver	  lipid	  accumulation.	  Tissue	  slides	  were	  placed	  in	  70%	  ethanol	  for	  10	  min	  and	  then	  removed	  and	  placed	  into	  saturated	  Oil	  Red	  O	  solution	  in	  70%	  ethanol	  for	  30	  min	  at	  60	  °C.	  Differentiation	  in	  70%	  ethanol	  was	  the	  final	  step	  before	  a	  wash	  in	  distilled	  water	  ended	  the	  reaction.	  Both	  IHC	  and	  Oil	  Red	  O	  stained	  sections	  were	  dehydrated	  in	  ethanol	  and	  organic	  solvent	  (histoclear)	  and	  then	  covered	  with	  glass	  held	  by	  Permount	  (Thermo	  Scientific).	  Quantification	  of	  both	  staining	  protocols	  was	  performed	  with	  microscopic	  imaging	  using	  MCID	  software	  (Imaging	  Research	  Inc)	  of	  sections	  chosen	  at	  random	  in	  each	  time	  point	  group.	  CD68	  was	  quantified	  by	  positive	  staining	  divided	  by	  the	  proportional	  tissue	  area.	  Oil	  Red	  O	  was	  quantified	  by	  positive	  staining	  divided	  by	  hepatocyte	  area	  using	  MCID	  quantification.	  	  
Blood	  Serum	  Analysis	  
	  Cardiac	  blood	  was	  collected	  from	  animals	  during	  perfusion	  and	  allowed	  to	  clot	  at	  room	  temperature	  for	  30	  mins	  after	  withdrawal.	  After	  centrifugation	  of	  clotted	  blood	  at	  3,000xG	  for	  10	  min,	  supernatant	  was	  collected	  and	  again	  centrifuged	  for	  3	  min	  at	  3,000xG	  to	  isolate	  blood	  serum.	  Serum	  was	  frozen	  at	  -­‐80	  °C	  until	  analysis.	  Serum	  levels	  of	  alanine	  transaminase	  were	  assessed	  by	  ELISA	  assay	  (Caymen	  Chemical,	  cat	  #700260).	  The	  assay	  was	  performed	  following	  the	  provided	  manufacturer’s	  instructions	  and	  normalized	  to	  a	  known	  standard.	  	  
Statistical	  Analysis	  of	  Data	  




Expression	  of	  adipokines	  is	  changed	  following	  spinal	  cord	  injury	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Previous	  studies	  shown	  above	  have	  shown	  the	  increased	  inflammation	  and	  lipid	  accumulation	  in	  the	  liver	  following	  injury.	  The	  present	  experiments	  were	  aimed	  at	  determining	  the	  presence	  and	  extent	  of	  these	  changes.	  Changes	  in	  adipose	  tissue	  and	  expression	  of	  adipokines,	  metabolic	  signaling	  factors	  derived	  from	  adipose	  tissue,	  were	  explored	  to	  examine	  changes	  in	  the	  primary	  fat	  storage	  organ.	  Adiponectin,	  resistin,	  and	  leptin	  were	  examined	  because	  of	  their	  inflammatory	  and	  metabolic	  effects	  on	  a	  target	  organ32,37.	  These	  adipokines	  act	  to	  alter	  the	  immune	  activation	  already	  observed	  after	  SCI.	  These	  changes	  begin	  with	  increased	  expression	  of	  all	  adipokine	  genes	  in	  visceral	  and	  retroperitoneal	  fat	  after	  cervical	  injury	  as	  shown	  in	  Fig	  2.1.	  The	  changes	  were	  significant	  compared	  to	  naïve	  levels	  for	  adiponectin	  and	  resistin	  in	  cervical	  injuries	  in	  visceral	  fat	  pads.	  While	  the	  other	  changes	  were	  not	  significant,	  resistin	  and	  leptin	  both	  show	  increasing	  transcription	  trends	  after	  both	  injury	  level	  types.	  Leptin	  expression	  is	  altered	  the	  least,	  as	  it	  is	  not	  significantly	  changed	  in	  neither	  visceral	  nor	  retroperitoneal	  fat	  tissue.	  Adiponectin	  
is	  not	  significantly	  increased	  after	  thoracic	  injury.	  These	  deviations	  would	  be	  expected	  to	  reveal	  similar	  changes	  in	  protein	  levels	  in	  adipose	  tissue	  and	  serum.	  Western	  blot	  analysis	  revealed	  that	  adipose	  tissue	  and	  serum	  levels	  of	  adiponectin	  
Figure	  2.1:	  The	  changes	  in	  adipokine	  gene	  transcription	  after	  spinal	  cord	  injury	  at	  different	  levels.	  Changes	   shown	   are	   based	   off	   fold	   changes	   from	   naïve	   tissue	   after	   normalization	   to	   18S	   gene	  transcription	  levels.	  (A)	  shows	  the	  changes	  of	  the	  three	  adipokines	  in	  visceral	   fat	  and	  (B)	  shows	  changes	  in	  retroperitoneal	  fat.	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and	  resistin	  are	  different	  after	  thoracic	  injury.	  Surprisingly,	  resistin	  protein	  levels	  decrease	  in	  retroperitoneal	  fat	  while	  staying	  unchanged	  in	  visceral	  fat.	  However,	  these	  levels	  are	  markedly	  changed	  in	  serum,	  as	  adiponectin	  decreases	  and	  resistin	  increases	  following	  injury	  as	  shown	  in	  Fig	  2.2	  (B)	  at	  21	  dpi	  following	  thoracic	  injury.	  	  	  
	  	   	  
Injury	  causes	  a	  change	  in	  hepatic	  lipid	  composition	  	   Previous	  studies	  have	  shown	  the	  pathological	  accumulation	  of	  hepatic	  lipids	  as	  soon	  as	  1	  dpi	  after	  injury,	  but	  did	  not	  investigate	  the	  composition	  of	  these	  lipids.	  Lipidomic	  analysis	  of	  liver	  tissue	  was	  used	  to	  determine	  the	  type	  of	  lipids	  that	  were	  changed	  in	  addition	  to	  the	  normal	  triglyceride	  increase.	  It	  was	  found	  that	  the	  composition	  of	  lipids	  in	  the	  liver	  was	  changed	  after	  SCI.	  Cytotoxic	  ceramide	  species	  were	  found	  to	  change	  in	  the	  liver	  following	  injury.	  Different	  ceramides	  showed	  significant	  increases	  or	  decreases.	  As	  shown	  in	  Fig	  2.3,	  ceramide	  and	  
Figure	   2.2:	   Changes	   in	  protein	   expression	   after	  different	   injury	   levels.	   (A)	  shows	   the	   changes	   in	  resistin	   expression	   in	  adipose	   tissue.	   (B)	   shows	  the	   changes	   in	   resistin	   and	  adiponectin	   expression	   in	  blood	   serum	   after	   thoracic	  injury.	   Changes	   in	  adiponectin	   in	   adipose	  tissue	  were	  not	  significantly	  different	  (data	  not	  shown.)	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lactosylceramide	  levels	  increased	  acutely	  after	  injury,	  but	  only	  lactosylceramide	  remained	  elevated	  up	  to	  42	  dpi.	  These	  changes	  are	  reflective	  of	  changes	  in	  other	  ceramide-­‐type	  lipid	  species	  after	  injury.	  This	  is	  paired	  with	  an	  increase	  in	  hepatic	  levels	  of	  the	  lipid-­‐soluble	  Vitamin	  E	  at	  3,	  14,	  and	  21	  dpi.	  It	  was	  also	  vital	  to	  determine	  the	  source	  of	  the	  increased	  ceramide	  species	  to	  find	  potential	  therapeutic	  targets	  to	  prevent	  hepatocyte	  damage	  from	  ceramide	  over	  accumulation.	  
The	  origin	  of	  the	  changing	  landscape	  of	  the	  fat	  stored	  in	  the	  liver	  was	  also	  explored	  with	  extensive	  gene	  profiling.	  Ceramides	  come	  from	  a	  common	  precursor	  (dihydroceramides)	  that	  can	  be	  derived	  from	  de	  novo	  synthesis	  methods	  within	  the	  liver	  or	  though	  salvage	  pathways	  using	  sphingomyelin	  as	  a	  metabolite33.	  It	  was	  found	  that	  the	  liver	  contributes	  to	  ceramide	  synthesis	  from	  a	  de	  novo	  pathway,	  as	  transcription	  for	  the	  rate-­‐limiting	  enzyme	  SPT	  (serine-­‐palmitoyl	  transferase)	  was	  increased	  at	  3	  and	  21	  dpi	  as	  shown	  in	  Fig	  2.4	  (A).	  	  In	  contrast,	  neutral	  Sphingomyelinase	  (nSMase),	  the	  enzyme	  responsible	  for	  the	  salvage	  pathway	  of	  ceramide	  synthesis,	  was	  unchanged	  from	  naïve	  levels	  through	  21	  dpi	  in	  Fig	  2.4	  (B).	  
Figure	   2.3:	   The	   composition	   of	   ceramide-­‐type	  lipids	  is	  changed	  in	  the	  liver	  following	  thoracic	  spinal	   cord	   injury.	   Some	   types	   are	   increased	  acutely	   before	   returning	   to	   naïve	   levels	   at	  chronic	   time	   points	   such	   as	   ceramide	   in	   (A).	  Other	   types	   remain	   elevated	   out	   to	   42	   dpi	   as	  observed	   in	   lactosylceramides,	   a	   further	  ceramide	   product,	   in	   (B).	   These	   changes	   are	  paired	   with	   an	   increase	   in	   the	   lipid-­‐soluble	  antioxidant	   vitamin	   E	   over	   the	   same	  approximate	   time	   course.	   (C)	   shows	   the	  increase	  in	  vitamin	  E	  that	  is	  another	  indication	  of	   lipid	   influx	   to	   the	   liver	   at	   chronic	   time	  points.	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Inflammatory	  gene	  expression	  is	  increased	  following	  injury	  
	  	   Previous	  studies	  have	  shown	  an	  enhanced	  inflammatory	  response	  in	  the	  liver	  acutely	  following	  injury	  as	  shown	  above.	  The	  increased	  activation	  of	  macrophages	  housed	  in	  the	  liver	  results	  from	  activation	  by	  cytokines,	  and	  it	  was	  important	  to	  determine	  which	  cytokines	  were	  increased	  that	  caused	  this	  activation.	  Therefore,	  changes	  in	  inflammatory	  genes	  were	  assessed	  out	  to	  3	  weeks	  post-­‐injury.	  	  Notably,	  tumor	  necrosis	  factor	  (TNF-­‐α)	  is	  significantly	  increased	  at	  14	  and	  21	  dpi	  as	  shown	  in	  Fig	  2.5	  (A).	  	  Interleukin-­‐6	  (IL-­‐6)	  and	  IL-­‐10	  are	  both	  cytokines	  secreted	  by	  immune	  
Figure	  2.4:	  Change	   in	  RNA	  expression	   in	   liver	   tissue	  of	   rate-­‐limiting	  enzymes	   in	  de	  novo	  and	  salvage	  pathway	  synthesis	  of	  ceramides.	  SPT	  mRNA	  shown	  in	  (A)	  is	  the	  rate	  limiting	  enzyme	  in	  de	  novo	  ceeramide	  synthesis.	  (B)	  shows	  nSMase	  RNA	  –	  the	  rate	  limiting	  enzyme	  in	  the	  salvage	  pathway	  that	  catabolizes	  sphingomyelin	  into	  ceramides.	  
Figure	   2.5:	   Expression	   of	   inflammatory	  genes	   is	   changed	   after	   thoracic	   injury.	  (A)	   shows	   the	   significant	   increase	   in	  TNF-­‐α	   at	   14	   and	   21	   dpi.	  While	   changes	  to	   expression	   of	   IL-­‐6	   (B)	   and	   IL-­‐10	   (C)	  are	   not	   significantly	   increased	   after	  injury,	   there	   is	   a	   trend	   towards	  increasing	   expression	   of	   both	   in	   the	  acute	  time	  points	  after	  injury.	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cells	  housed	  in	  the	  liver	  that	  modulate	  the	  inflammatory	  state	  of	  the	  immune	  system.	  IL-­‐6	  is	  a	  pro-­‐inflammatory	  cytokine	  that	  enhances	  inflammation,	  and	  IL-­‐10	  an	  anti-­‐inflammatory	  cytokine	  that	  acts	  counteractively	  to	  decrease	  the	  inflammatory	  state.	  Neither	  cytokine	  shows	  significant	  changes	  after	  injury,	  but	  both	  show	  trending	  towards	  increased	  levels	  in	  acute	  time	  points.	  	  
Cervical	  spinal	  cord	  injury	  produces	  comparable	  liver	  dysfunction	  as	  thoracic	  spinal	  
cord	  injury	  	   Fatty	  liver	  pathology	  and	  increased	  hepatic	  inflammation	  are	  both	  observed	  after	  thoracic	  level	  injury,	  but	  a	  critical	  aspect	  of	  determining	  the	  extent	  of	  the	  pathology	  was	  to	  determine	  their	  applicability	  to	  the	  heterogeneous	  injury	  types	  of	  the	  SCI	  patient	  population.	  The	  lipid	  accumulation	  and	  inflammation	  in	  the	  liver	  observed	  during	  thoracic	  injury	  were	  also	  observed	  in	  cervical	  injured	  animals.	  
Increased	  liver	  lipid	  content	  was	  observed	  as	  soon	  as	  1	  dpi	  and	  remains	  elevated	  chronically	  out	  to	  21	  dpi.	  Furthermore,	  transcription	  levels	  of	  the	  pro-­‐inflammatory	  cytokines	  IL-­‐1α	  and	  IL-­‐1β	  both	  increased	  chronically	  following	  cervical	  and	  thoracic	  spinal	  cord	  injury.	  While	  these	  changes	  are	  not	  significant	  for	  cervical	  injury,	  the	  increasing	  trends	  are	  evident	  from	  the	  plots	  shown	  in	  Fig	  2.7.	  Unlike	  the	  increases	  in	  other	  inflammatory	  genes,	  IL-­‐1α	  decreased	  acutely	  before	  returning	  to	  naive	  levels.	  Confirming	  the	  development	  of	  liver	  pathology	  following	  cervical	  injury,	  serum	  
Figure	  2.6:	  Liver	  lipid	  content	  as	  detected	  by	  the	  Oil	  Red	  O	  stain	  is	  increased	  following	  C5	  cervical	  spinal	  cord	  injury	  as	  compared	  to	  naïve	  levels.	  These	  changes	  mirror	  those	  observed	  in	  thoracic	  spinal	  cord	  injury.	  1	  and	  3	  dpi	  are	  significantly	  elevated	  with	  p<0.01	  compared	  to	  naïve	  content.	  After	  no	   significant	   change	   is	  observed	  at	  7	  dpi	   (similar	   to	   thoracic	   injury),	   significant	   increase	  occurs	  chronically	  at	  21	  dpi	  with	  p<0.05	  compared	  to	  naïve	  tissue.	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levels	  of	  ALT	  are	  increased	  at	  21	  dpi	  as	  shown	  in	  Fig	  2.8.	  The	  timing	  of	  this	  increase	  closely	  resembles	  the	  rate	  of	  significant	  serum	  ALT	  levels	  following	  thoracic	  injury.	  	  
	  
Discussion	  
	   The	  changes	  invoked	  by	  SCI	  in	  adipose	  tissue	  caused	  a	  shift	  in	  expression	  of	  adipokines,	  which	  can	  produce	  a	  myriad	  of	  inflammatory	  changes.	  Metabolic	  changes	  are	  also	  enacted	  in	  response	  to	  these	  factors,	  notable	  enhancement	  of	  fat-­‐metabolizing	  β-­‐oxidation	  by	  adiponectin	  and	  a	  decrease	  in	  this	  same	  fatty	  acid	  catabolism	  reaction	  when	  resistin	  is	  present28.	  It	  is	  important	  to	  consider	  adipokine	  levels	  in	  both	  adipose	  tissue	  and	  serum	  as	  changes	  in	  adipose	  tissue	  would	  alter	  the	  metabolic	  profile	  of	  fat	  tissue,	  and	  serum	  levels	  would	  change	  metabolic	  effects	  in	  
Figure	  2.7:	  Transcription	  of	  proinflammatory	  IL-­‐1	  genes	  following	  cervical	  and	  thoracic	  injury.	  (A)	   shows	   IL-­‐1α	  and	   (B)	   shows	   IL-­‐1β	   transcription	   levels.	  These	   follow	  similar	  patterns	  with	  the	  exception	  of	  the	  slight	  decrease	  of	  IL-­‐1α	  expression	  acutely	  after	  cervical	  injury.	  	  
	  
Figure	  2.8:	  Serum	  levels	  of	  alanine	  transaminase	  after	  cervical	   injury.	  At	  21	  dpi,	   levels	  of	  ALT	  are	   significantly	   elevated	   compared	   to	   naïve	   as	  well	   as	   3	   and	   7	   dpi.	   The	   time	   course	   of	   this	  increase	  follows	  a	  pattern	  similar	  to	  thoracic	  injury.	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other	  peripheral	  organs	  such	  as	  the	  liver.	  Metabolic	  consequences	  result	  from	  altered	  adipokine	  expression	  in	  both	  adipose	  tissue	  and	  in	  the	  liver.	  Adipose	  tissue	  also	  plays	  a	  key	  role	  in	  initiation	  of	  the	  inflammatory	  response22.	  A	  pro-­‐inflammatory	  adipokine	  response	  can	  damage	  the	  liver	  and	  drive	  chronic	  liver	  dysfunction.	  	  From	  these	  studies	  it	  is	  clear	  that	  adipokine	  expression	  is	  changed	  after	  cervical	  or	  thoracic	  injury.	  However,	  differences	  in	  the	  direction	  of	  gene	  and	  protein	  changes	  make	  interpreting	  these	  changes	  somewhat	  difficult.	  While	  leptin	  does	  not	  demonstrate	  a	  significant	  change	  in	  expression,	  both	  adiponectin	  and	  resistin	  expression	  is	  altered	  following	  injury	  in	  adipose	  tissue.	  The	  present	  data	  demonstrates	  that	  resistin,	  a	  factor	  indicted	  in	  propagating	  an	  inflammatory	  immune	  response19,	  is	  the	  adipokine	  most	  increased	  after	  spinal	  cord	  injury.	  As	  this	  pro-­‐inflammatory	  adipokine	  migrates	  to	  the	  liver	  via	  the	  blood	  stream,	  it	  would	  help	  prolong	  the	  inflammatory	  state	  caused	  by	  the	  initial	  injury.	  This	  supports	  previous	  observations	  that	  show	  chronic	  liver	  inflammation	  out	  to	  42	  dpi,	  and	  resistin	  likely	  prolongs	  this	  inflammatory	  state.	  Unusually,	  this	  increase	  in	  gene	  expression	  of	  resistin	  shown	  in	  Fig	  2.1	  is	  coupled	  with	  a	  decrease	  in	  resistin	  protein	  content	  in	  adipose	  tissue	  as	  shown	  in	  Fig	  2.2	  (A).	  This	  could	  be	  explained	  by	  the	  increase	  in	  serum	  resistin	  content	  in	  the	  same	  time	  course.	  As	  resistin	  is	  produced	  by	  adipocytes,	  most	  of	  it	  is	  shipped	  out	  through	  blood	  to	  aid	  the	  immune	  system	  by	  initiating	  an	  inflammatory	  response	  and	  to	  alter	  the	  metabolic	  landscape	  to	  provide	  the	  organism	  with	  fuel	  to	  enact	  these	  changes.	  Adiponectin	  is	  also	  increased	  following	  cervical	  injury	  as	  shown	  in	  Fig	  2.1,	  while	  it	  is	  statistically	  unchanged	  during	  thoracic	  injury.	  Adiponectin	  is	  anti-­‐inflammatory	  in	  nature	  and	  helps	  regulate	  blood	  glucose	  levels	  by	  catabolism	  of	  lipids	  via	  β-­‐oxidation.	  Adiponectin	  acts	  antagonistically	  to	  resistin32,	  and	  it	  is	  interesting	  to	  note	  that	  the	  expression	  of	  both	  genes	  is	  increased	  following	  cervical	  injury.	  Despite	  their	  antagonistic	  effects,	  both	  adipokines	  are	  produced	  in	  healthy,	  uninjured	  adipose	  tissue,	  and	  their	  paired	  increased	  expression	  should	  only	  serve	  to	  initiate	  the	  physiological	  changes	  needed	  to	  respond	  to	  traumatic	  cervical	  injury.	  However,	  in	  the	  thoracic	  injury	  model,	  adiponectin	  was	  not	  significantly	  increased	  as	  contrasted	  to	  the	  cervical	  injury	  model.	  It	  is	  evident	  from	  the	  presented	  data	  that	  the	  injury	  alters	  the	  landscape	  of	  adipokine	  expression.	  	  Mobilization	  of	  lipids	  to	  the	  liver	  is	  one	  change	  observed	  that	  is	  connected	  to	  the	  changed	  expression	  of	  adipokines	  following	  injury.	  The	  decrease	  in	  serum	  adiponectin	  and	  increase	  in	  serum	  resistin	  after	  21	  dpi	  provides	  the	  strongest	  evidence	  that	  adipose	  tissue	  plays	  a	  role	  in	  pathogenesis	  of	  NAFLD/NASH.	  As	  serum	  levels	  of	  resistin	  are	  increased	  without	  the	  balancing	  effects	  of	  adiponectin,	  its	  effect	  on	  peripheral	  organs	  becomes	  more	  pronounced.	  One	  effect	  of	  this	  imbalance	  is	  insulin	  resistance5.	  Resistin	  has	  been	  linked	  to	  insulin	  resistance,	  and	  adiponectin	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has	  been	  shown	  to	  induce	  insulin	  sensitivity13,28.	  The	  serum	  levels	  shown	  in	  Fig	  2.2	  (B)	  indicate	  that	  insulin	  resistance	  can	  result	  from	  this	  imbalance.	  As	  cells	  become	  insulin	  resistant,	  lipolysis	  of	  triglycerides	  in	  adipose	  tissue	  begins	  to	  export	  FFAs	  to	  liver	  tissue	  for	  transformation	  into	  glucose.	  The	  enhanced	  levels	  of	  serum	  resistin	  after	  thoracic	  SCI	  would	  also	  allow	  the	  liver	  to	  remain	  in	  a	  state	  of	  chronic	  inflammation.	  This	  could	  help	  explain,	  in	  part,	  the	  chronic	  inflammation	  and	  lipid	  accumulation	  of	  the	  liver	  leading	  to	  NAFLD	  as	  observed	  in	  previous	  and	  the	  current	  studies.	  However,	  the	  specific	  function	  of	  each	  of	  these	  adipokines	  is	  still	  not	  clearly	  defined28.	  Ultimately,	  more	  studies	  are	  needed	  to	  determine	  the	  precise	  changes	  and	  functions	  of	  adipokines	  after	  SCI	  in	  generating	  metabolic	  and	  inflammatory	  changes.	  Even	  so,	  the	  present	  studies	  provide	  promising	  evidence	  that	  future	  endeavors	  in	  this	  area	  will	  prove	  worthwhile.	  	   The	  changes	  of	  adipokine	  expression	  in	  the	  adipose	  tissue	  would	  have	  far	  reaching	  metabolic	  consequences,	  most	  notably	  in	  the	  liver	  as	  the	  primary	  metabolic	  organ.	  Previous	  studies	  have	  shown	  the	  chronic	  accumulation	  of	  lipids	  in	  the	  liver	  after	  thoracic	  spinal	  cord	  injury.	  Given	  that	  the	  Oil	  Red	  O	  stain	  used	  for	  this	  analysis	  is	  non-­‐specific	  in	  its	  binding	  to	  lipid	  species,	  it	  was	  important	  to	  determine	  the	  lipid	  species	  that	  are	  altered	  after	  thoracic	  injury.	  Notably,	  ceramide	  content	  is	  increased	  in	  the	  liver	  following	  thoracic	  injury.	  Ceramide	  precursors	  (dihyroxyceramides),	  mature	  ceramide,	  and	  ceramide	  products	  (lactosylceramides)	  are	  all	  increased	  in	  the	  liver.	  Ceramides	  act	  as	  signaling	  molecules	  that	  act	  as	  second	  messengers	  in	  apoptosis	  signaling	  cascades,	  and	  their	  prolonged	  presence	  can	  lead	  to	  oxidative	  damage14,40.	  These	  cytotoxic	  effects	  cause	  ceramides	  to	  exacerbate	  liver	  pathology	  and	  are	  a	  further	  indication	  of	  liver	  dysfunction.	  	  Ceramides	  have	  also	  been	  shown	  to	  be	  important	  in	  the	  pathogenesis	  of	  NAFLD	  and	  progression	  to	  NASH27,33,38.	  Their	  overexpression	  has	  been	  linked	  with	  insulin	  resistance,	  particularly	  in	  the	  liver,	  as	  well	  as	  furthering	  recruitment	  of	  inflammatory	  cells.	  This	  is	  even	  more	  concerning	  because	  of	  the	  rapid	  onset	  of	  these	  changes	  –	  as	  soon	  as	  1	  dpi.	  While	  some	  species	  –	  such	  as	  mature	  ceramide	  –	  return	  to	  baseline	  levels	  after	  the	  acute	  increase,	  other	  species	  remain	  elevated	  chronically	  to	  at	  least	  42	  dpi.	  The	  initial	  liver	  steatosis	  and	  inflammation	  is	  only	  enhanced	  by	  the	  chronic	  increase	  in	  ceramide	  content	  and	  may	  aid	  in	  progression	  of	  liver	  dysfunction	  to	  clinical	  relevance.	  Vitamin	  E	  levels	  increase	  in	  the	  liver	  following	  the	  same	  time	  course	  as	  changes	  to	  ceramide	  content.	  As	  a	  lipid	  soluble	  vitamin,	  the	  increasing	  levels	  of	  Vitamin	  E	  are	  further	  evidence	  of	  enhanced	  fat	  accumulation	  in	  the	  liver.	  Vitamin	  E	  is	  a	  potent	  antioxidant,	  and	  its	  presence	  can	  help	  to	  prevent	  the	  cytotoxic	  oxidative	  damage	  brought	  about	  by	  prolonged	  ceramide	  increase.	  Its	  increase	  is	  a	  result	  of	  increased	  hepatic	  lipid	  influx,	  but	  its	  antioxidant	  properties	  
	   20	  
would	  suit	  the	  post-­‐injury	  fatty	  liver	  environment.	  It	  is	  also	  a	  potential	  therapeutic	  target	  as	  previous	  studies	  have	  shown	  its	  preventative	  effects	  in	  liver	  dysfunction34.	  	  Data	  shown	  in	  Fig	  2.4	  shows	  the	  origin	  of	  the	  ceramide	  increase.	  The	  up	  regulation	  of	  gene	  expression	  for	  SPT	  indicates	  that	  the	  source	  of	  increased	  liver	  ceramide	  content	  is	  the	  de	  novo	  synthesis	  from	  the	  liver	  itself.	  Excess	  ceramides	  are	  not	  generated	  from	  breakdown	  of	  the	  plasma	  membrane	  component	  sphingomyelin	  because	  nSMase	  expression	  is	  not	  significantly	  changed	  after	  injury.	  Ceramides	  act	  as	  a	  second	  messenger	  through	  programmed	  cell	  death,	  particularly	  through	  tumor	  necrosis	  factor	  signaling,	  mainly	  through	  TNF-­‐α26.	  However,	  their	  appearance	  in	  properly	  functioning	  tissue	  is	  typically	  due	  to	  the	  breakdown	  of	  membranous	  sphingomyelin	  by	  nSMase3,14.	  Thus	  the	  unchanged	  nSMase	  expression	  coupled	  with	  enhanced	  SPT	  expression	  is	  indicative	  of	  dysfunction.	  Inhibition	  of	  de	  novo	  ceramide	  synthesis	  enzymes	  has	  been	  shown	  to	  reduce	  lipid	  accumulation	  in	  NAFLD	  patients21.	  The	  increased	  SPT	  expression	  after	  injury	  gives	  promising	  evidence	  that	  this	  treatment	  could	  also	  be	  applied	  as	  a	  therapeutic	  measure	  to	  the	  SCI	  patient	  population	  to	  combat	  fatty	  liver	  pathology.	  A	  “multiple	  hit”	  pathophysiology	  is	  most	  accepted	  in	  the	  medical	  community	  for	  development	  of	  NAFLD	  and	  NASH,	  and	  elimination	  of	  increased	  ceramide	  expression	  would	  remove	  the	  “hits”	  of	  inflammation	  and	  insulin	  resistance	  involved	  in	  development	  of	  pathology.	  	  	   Changes	  in	  cytokine	  expression	  are	  observed	  in	  development	  of	  NAFLD	  and	  NASH	  in	  the	  uninjured	  population,	  notably	  the	  increase	  in	  TNF-­‐α	  expression7,45.	  This	  same	  trend	  occurs	  in	  spinal	  cord	  injury,	  with	  significant	  increases	  developing	  in	  thoracic	  injury	  as	  soon	  as	  two	  weeks	  post	  injury.	  TNF-­‐α	  is	  secreted	  directly	  by	  hepatocytes	  and	  in	  adipose	  tissue	  as	  a	  mediator	  of	  the	  inflammatory	  response,	  leading	  to	  its	  association	  with	  development	  of	  NASH16.	  The	  significant	  increase	  at	  14	  and	  21	  dpi	  is	  another	  marker	  of	  rapid	  pathological	  progression	  in	  the	  liver.	  TNF-­‐α	  has	  several	  roles	  in	  mediating	  the	  inflammatory	  response,	  and	  one	  way	  it	  accomplishes	  this	  is	  through	  increasing	  ceramide	  synthesis	  by	  enhancing	  SPT	  expression6.	  This	  follows	  earlier	  observations	  that	  show	  increases	  in	  ceramides	  by	  the	  de	  novo	  synthesis	  pathway	  of	  which	  SPT	  is	  the	  rate-­‐limiting	  enzyme.	  Also	  shown	  in	  Fig	  2.5	  (B)	  is	  the	  non-­‐significant	  change	  in	  IL-­‐6	  expression.	  IL-­‐6	  plays	  a	  rather	  paradoxical	  role	  in	  liver	  dysfunction,	  and	  while	  it	  acts	  as	  a	  pro-­‐inflammatory	  cytokine,	  it	  has	  also	  been	  shown	  to	  have	  protective	  action	  for	  hepatocytes39.	  Despite	  trending	  towards	  increased	  expression,	  IL-­‐6	  is	  not	  significantly	  changed	  after	  injury.	  IL-­‐10	  has	  also	  been	  studied	  for	  its	  protective	  effects	  on	  hepatocytes	  against	  lipotoxicity	  from	  fatty	  liver	  pathology.	  Levels	  of	  IL-­‐10	  have	  been	  inversely	  correlated	  with	  metabolic	  syndrome,	  and	  can	  protect	  against	  further	  progression	  of	  NAFLD	  and	  NASH45.	  IL-­‐10	  shows	  the	  least	  amount	  of	  change	  relative	  from	  naïve	  levels	  and,	  like	  IL-­‐6,	  is	  not	  significantly	  changed	  after	  injury.	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The	  increase	  in	  inflammatory	  TNF-­‐α	  without	  the	  increase	  in	  protective	  IL-­‐6	  or	  IL-­‐10	  is	  evidence	  of	  further	  liver	  damage.	  Without	  anti-­‐inflammatory	  effects	  of	  IL-­‐10	  or	  adiponectin,	  TNF-­‐α	  and	  ceramides	  produce	  a	  self-­‐proliferating	  cycle	  of	  inflammatory	  changes	  in	  the	  liver33.	  Some	  evidence	  has	  shown	  anti-­‐TNF-­‐α	  treatment	  to	  be	  effective	  in	  ameliorating	  liver	  steatosis	  and	  inflammation,	  but	  these	  studies	  were	  performed	  in	  uninjured	  animals	  on	  a	  high-­‐fat	  diet35.	  It	  would	  be	  important	  to	  consider	  the	  ramifications	  of	  exploring	  this	  treatment	  option	  in	  patients	  reacting	  to	  a	  traumatic	  SCI.	  As	  TNF-­‐α	  is	  involved	  in	  regulation	  of	  the	  immune	  response	  after	  injury,	  therapeutic	  targets	  for	  SCI-­‐patients	  with	  NASH	  could	  best	  be	  targeted	  elsewhere	  to	  prevent	  attenuation	  of	  the	  innate	  response	  necessary	  for	  proper	  healing.	  	   It	  is	  critical	  to	  remember	  that	  spinal	  cord	  injury	  to	  different	  levels	  of	  the	  cord	  could	  have	  different	  functional	  consequences	  for	  the	  regulation	  of	  the	  liver11.	  Primary	  sympathetic	  afferents	  that	  directly	  control	  liver	  function	  are	  housed	  in	  the	  thoracic	  spinal	  cord.	  Damage	  to	  the	  thoracic	  region	  would	  damage	  these	  direct	  inputs	  to	  the	  liver,	  allowing	  it	  to	  act	  with	  only	  parasympathetic	  input.	  Damage	  to	  the	  cervical	  cord	  would	  result	  in	  damage	  to	  the	  descending	  control	  of	  the	  sympathetic	  nervous	  system,	  but	  would	  still	  allow	  the	  sympathetic	  neurons	  in	  the	  thoracic	  cord	  to	  act	  independently	  of	  higher	  CNS	  control.	  However,	  the	  data	  provides	  evidence	  that	  cervical	  injury	  produces	  comparable	  liver	  dysfunction	  as	  thoracic	  injury.	  Liver	  lipid	  content	  as	  shown	  in	  Fig	  2.6	  shows	  significant	  accumulation	  over	  the	  same	  time	  course	  as	  thoracic	  injury.	  Production	  of	  inflammatory	  cytokines	  IL-­‐1α	  and	  IL-­‐1β	  in	  the	  liver	  is	  also	  increased	  chronically	  in	  both	  injury	  models.	  These	  changes	  in	  liver	  function	  after	  cervical	  injury	  mimic	  the	  fatty	  and	  inflamed	  livers	  associated	  with	  thoracic	  injury.	  It	  can	  be	  concluded	  that	  both	  cervical	  and	  thoracic	  injury	  types	  result	  in	  a	  fatty	  and	  inflamed	  liver	  and	  produce	  comparable	  liver	  dysfunction.	  	  One	  notable	  trend	  in	  both	  injury	  types	  is	  the	  pattern	  of	  lipid	  accumulation	  and	  inflammation	  after	  injury.	  After	  the	  initial	  increase	  in	  the	  acute	  phase	  (1-­‐3	  dpi),	  there	  is	  a	  return	  to	  naïve	  levels	  around	  7	  dpi	  and	  then	  a	  chronic	  increase	  that	  becomes	  significant	  at	  21	  dpi	  (see	  Figs	  1.1,	  1.2,	  2.6).	  It	  is	  possible	  that	  this	  pattern	  is	  due	  to	  a	  prolongation	  of	  the	  acute	  phase	  response.	  Sham	  controls	  mimic	  the	  changes	  seen	  for	  the	  first	  few	  days	  after	  injury,	  but	  do	  not	  show	  the	  chronic	  increased	  observed	  in	  injured	  animals.	  Damage	  to	  the	  nervous	  system	  may	  impair	  a	  return	  to	  normal	  physiological	  function,	  and	  imbalances	  steadily	  become	  more	  pronounced	  after	  the	  acute	  phase	  response	  has	  attempted	  to	  return	  to	  normal	  function.	  The	  similar	  changes	  observed	  in	  the	  two	  injury	  groups	  indicate	  that	  the	  conclusions	  made	  from	  these	  studies	  would	  be	  applicable	  to	  a	  broad	  patient	  base,	  and	  more	  specific	  determinants	  would	  be	  necessary	  to	  differentiate	  between	  cervical	  and	  thoracic	  injury	  on	  liver	  dysfunction.	  Future	  studies	  may	  seek	  to	  examine	  if	  lumbar	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level	  injuries	  cause	  a	  similar	  liver	  dysfunction,	  as	  a	  lumbar	  injury	  damages	  neither	  sympathetic	  output	  nor	  descending	  control	  of	  autonomic	  liver	  innervation.	  	   Pathological	  changes	  in	  the	  liver	  occur	  after	  both	  cervical	  and	  thoracic	  SCI	  and	  are	  characterized	  by	  increased	  lipid	  accumulation	  including	  changes	  to	  ceramide	  composition,	  inflammation,	  and	  release	  of	  alanine	  transaminase.	  Notably,	  the	  array	  of	  post-­‐SCI	  hepatic	  changes	  mimics	  the	  condition	  of	  non-­‐alcoholic	  steatohepatitis,	  which	  is	  associated	  with	  insulin	  resistance,	  peripheral	  inflammation,	  and	  metabolic	  syndrome.	  This	  condition	  is	  concerning	  because	  it	  can	  progress	  to	  liver	  cirrhosis.	  The	  only	  accepted	  current	  treatment	  for	  NAFLD-­‐like	  pathology	  is	  body	  weight	  loss,	  which	  is	  often	  not	  a	  viable	  option	  for	  SCI	  patients	  because	  of	  mobility	  limitations.	  Given	  the	  liver’s	  essential	  role	  in	  metabolic	  function	  and	  the	  known	  metabolic	  problems	  after	  SCI,	  these	  studies	  serve	  as	  an	  important	  first	  step	  to	  identify	  novel	  therapeutic	  targets	  for	  improving	  health,	  longevity,	  and	  quality	  of	  life	  for	  SCI	  patients.	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